Ad Astra Diagnostics, Inc.
Country not established
- Devices
- 1
What Ad Astra Diagnostics, Inc. makes
Ad Astra Diagnostics, Inc. manufactures the QScout Lab and QScout RLD, which are portable, handheld devices designed for rapid, point-of-care testing of blood glucose levels and related metrics in clinical and home settings.
These devices are classified as Class II under FDA regulations and are listed via 510(k) clearance. The company is based in the United States.
Catalogue
QScout Lab; QScout RLD Ref K230878
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Ad Astra Diagnostics, Inc. have in the registry?
The registry currently lists 1 device for Ad Astra Diagnostics, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Ad Astra Diagnostics, Inc.'s devices?
Among its 1 most recently registered device, Ad Astra Diagnostics, Inc. has devices listed in FDA 510(k) (1 device).
What risk classes do Ad Astra Diagnostics, Inc.'s devices fall under?
Among its 1 most recently registered device, the classes recorded for Ad Astra Diagnostics, Inc.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Ad Astra Diagnostics, Inc. in the registry?
The most recently registered devices listed for Ad Astra Diagnostics, Inc. include QScout Lab; QScout RLD.